RESULTS OF HOSPITAL USE OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION

Aim. To assess effectiveness and safety of the hospital use of recombinant non-immunogenic staphylokinase in patients with acute  ST-elevated myocardial infarction (STEMI).Material and methods. Recombinant non-immunogenic staphylokinase was administered during in-hospital stage of treatment of 93 pa...

ver descrição completa

Detalhes bibliográficos

Autor principal:	V. B. Kostogryz
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Столичная издательская компания 2017-03-01
coleção:	Рациональная фармакотерапия в кардиологии
Assuntos:	acute st-elevated myocardial infarction thrombolytic therapy recombinant non-immunogenic staphylokinase
Acesso em linha:	https://www.rpcardio.online/jour/article/view/1416
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!